FDA grants speedy approval to Eli Lilly’s weight-loss GLP-1 pill Foundayo for obesity
Federal regulators on Wednesday approved Eli Lilly’s new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions. The U.S. Food and Drug Administration has granted accelerated approval to orforgliprone, a GLP-1 drug that works like widely used injectable drugs to mimic the natural hormone that controls appetite and feelings of … Read more